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Bai et al. (14) . p21 effectively inhibits Cdk2, Cdk3, Cdk4 and Cdk6, which have a direct role in the G 1 /S transition, but it is a poor inhibitor of other known Cdks (15) (16) (17) . Cyclin proteolysis is essential for cell cycle by guest on January 1, 2018
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progession (18, 19) . Cyclin D1 regulates G 1 arrest and the phosphorylation status of retinoblastoma protein (Rb). Cyclin D1 degradation is mediated by phosphorylationtriggered, ubiquitin-dependent proteolysis (20) . Cyclin D1 proteolysis is regulated by glycogen synthase kinase-3b (GSK-3b) (21) , which is inactivated by a pathway that sequentially involves Ras, phosphatidylinositol 3-kinase (PI3K), and Akt (protein kinase B) (22) .
The aim of this study is to examine the mechanisms whereby MPP + inhibits cell proliferation. We show here that MPP + initiates an efficient p53-independent G 1 arrest by the degradation of cyclin D1.
Methods:
Reagents and cells 
Western blot analysis
Cells were collected and washed twice with ice-cold phosphate buffered saline 
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Western blot detection kit (Amershan Pharmacia Biotech).
Cell cycle analysis by flow cytometry
After the fixation with ethanol, the cells were treated with 50 mg/ml propidium iodide (Calbiochem) and analyzed by flow cytometer (FACSCalibur, Becton Dickinson) using CELLQUEST software.
Northern blot analysis
Total RNA was extracted using TRIzol reagent according to the manufacturer's instructions (26) . Ten micrograms of total RNA was electrophoresed, and transferred to Maximum strength Nytran nylon (Schleicher and Schrul, Knee, NH) with a Turbo-Blotter system (Schleicher and Schrul). The filter was hybridized with human cyclin D1 cDNA probe.
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Results
MPP + suppresses the cell growth of p53-deficient MG63 cells
Previous study showed that dopamine neurons from p53-knockout mice are resistant to MPTP neurotoxicity (27), suggesting that MPP + -induced apoptosis is at least partly mediated by p53 (28) . To dissect the p53-independent effect of MPP + , we first examined whether MPP + suppresses the growth of p53-deficient MG63 osteosarcoma cells.
As shown in Fig. 1 To examine the mechanism whereby MPP + inhibits cell proliferation, the cell cycle was analyzed using a flow cytometer (FACS). The MG63 cells were incubated in DMEM with 0.5% FCS for 48 h to synchronize cells in G 0 /G 1 ( Fig. 2A) . Then, these cells were phase (Fig. 2C) , whereas the control treatment markedly increased the population in S phase (Fig. 2B ).
We next investigated whether the MPP + -induced G 1 arrest was accompanied by changes of Rb phosphorylation status (29) . As expected, hypophosphorylated form of Rb increased after MPP + treatment (Fig. 3A) . However, MPP + did not increase p21 protein level in p53-deficient MG63 cells (Fig. 3B) , suggesting that MPP + induces p53, p21-independent G 1 arrest in MG63 cells. Bai et al.
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progression through the cell cycle (30) , and the downregulation of cyclin D1 plays an important role in the cell cycle arrest. Therefore, we focused on the change of cyclin D1 expression levels after MPP + treatment. Although MPP + suppressed the protein expression of cyclin D1 in dose-dependent and time-dependent manners (Fig.4A, B) , MPP + did not decrease the mRNA levels of cyclin D1 (Fig. 4C) . These results indicate that the decrease of cyclin D1 levels is regulated by the posttranscriptional mechanism. Furthermore, MG132, a proteasome inhibitor, suppressed MPP + -induced decrease in cyclin D1 protein level ( 14 status or mitochondrial function in target cells.
PI3K-Akt-GSK-3b pathway regulates MPP + -mediated cyclin D1 proteolysis
Ubiquitin-proteaseome-dependent degradation of cyclin D1 requires phosphorylation of the protein by GSK-3b, which is phosphorylated and inactivated by Akt (20) . We therefore examined whether the PI3K-Akt-GSK-3b pathway is involved in MPP + -induced degradation of cyclin D1. Using PC12 cells, we demonstrated that MPP + dephosphorylated Akt, and that the pretreatment with nerve growth factor (NGF) rescued the dephosphorylation (Fig. 6A) . The phosphorylation of GSK-3b was augmented by the combined treatment with NGF and MPP + (Fig. 6A ). As shown in 
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Discussion
In the present study, we showed that MPP + inhibits cell proliferation with accumulation in G 1 phase and hypophosphorylation of Rb in p53-deficient MG63 cells (Fig.   2C, 3A) . In general, G 1 cell cycle arrest is induced by p53-dependent or p53-independent accumulation of p21, which inhibits cyclin-E/CDK2 activity and the G1-S transition (34, 35) . Our results indicate that p53 is not associated with MPP + -induced growth inhibition.
Although it has been reported that MPP + inhibits the proliferation of PC12 cells by a p21-dependent pathway (6), MPP + did not increase p21 protein levels in MG63 cells (Fig. 3B ).
These results suggest that MPP + can inhibit cell proliferation independently of p53 or p21.
Cyclin proteolysis is essential for cell cycle progession (36) . Inhibition of cyclin D1 expression either by antisense methodology or antibody microinjection lengthens the duration of the G 1 phase and suppresses cell proliferation (37, 38) . Although cyclin D1
protein levels were rapidly downregulated by MPP + within 4 h (Fig. 4B) , the mRNA level of cyclin D1 did not decrease (Fig. 4C) , suggesting that the downregulation of cyclin D1 is 
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regulated by the posttranscriptional mechanism. We showed that MPP + -induced decrease in cyclin D1 protein levels was suppressed by proteasome inhibitors, MG132 (Fig. 4D) or Nacetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL) (data not shown). These data suggest that MPP + downregulates cyclin D1 through the ubiquitin-proteasome pathway (20) .
MPP + inhibits NADH dehydrogenase activity in mitochondrial complex I (8-10).
However, we demonstrated that MPP + downregulated cyclin D1 in HeLa and HeLa r 0 cells (Fig. 5B, C) , indicating that the downregulation of cyclin D1 is not associated with the inhibition of mitochondrial complex I by MPP + and that MPP + has an extramitochondrial molecular target. GSK-3b was reported to regulate cyclin D1 proteolysis (21) . We showed that a GSK-3b specific inhibitor, LiCl, suppresssed the MPP + -induced downregulation of cyclin D1 protein levels (Fig. 6B, C) , suggesting the involvement of the GSK-3b pathway in the downregulation of cyclin D1. Akt inactivates GSK-3b through site-specific phosphorylation, resulting in the inhibition of cyclin D1 turnover (21) . We demonstrated 
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inhibitor of GSK-3b, LiCl (Fig. 6A, B) . 
